Detalhe da pesquisa
1.
A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipients.
J Hepatol
; 77(3): 702-709, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35452692
2.
Immunogenicity and Adverse Effects of the 2-Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients.
Liver Transpl
; 28(2): 215-223, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767690
3.
Noninvasive Assessment of Fibrosis Regression after Direct-acting Antiviral Treatment in Hepatitis C Virus Patients.
Isr Med Assoc J
; 23(12): 794-800, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34954919
4.
Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients.
Viruses
; 15(1)2023 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36680292
5.
Research trends analysis of chronic hepatitis C versus nonalcoholic fatty liver disease: A literature review text-mining analysis of publications.
Health Sci Rep
; 5(6): e805, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36415562
6.
High Immune Response Rate to the Fourth Boost of the BNT162b2 Vaccine against the Omicron Variants of Concern among Liver Transplant Recipients.
Viruses
; 14(12)2022 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36560773
7.
XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis.
Nat Med
; 27(6): 1043-1054, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34017133
8.
Publisher Correction: XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis.
Nat Med
; 28(1): 214, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35022579